Response to purine-containing compound

pathway activity — cross-omics
GO:0014074Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Response to purine-containing compound pathway is significantly associated with the RNA expression of multiple genes, with the BRCA cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are TACO1, ATIC, and IGKV1D-13, each associated with the pathway in up to 5 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Response to purine-containing compound activity versus TACO1 in BRCA (Pearson r = -0.41).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BRCATACO1 →-0.425-0.126<.001<.00135
BRCAATIC →-0.387-0.153<.001<.00134
OVIGKV1D-13 →+1.376+0.143.007.00234
BRCAMRPS7 →-0.287-0.109.007.00134
BRCATK1 →-0.787-0.145.001.00334
BRCATRAIP →-0.560-0.159<.001.00334
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0014074 vs TACO1 — BRCA

Per-sample scatter of Response to purine-containing compound activity vs TACO1 in BRCA.

Explore this scatter interactively →

Exploration